Drug or technology

empagliflozin

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 2 TRIAL

Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease

ClinicalTrials.gov

This is a Phase 2 interventional trial registered but not yet recruiting, with no results posted; it represents early-phase work to evaluate safety and tolerability of adjunctive therapies in Alzheimer's disease.

PreliminaryNCT07756294 Insulin Placebo Alzheimer Disease

Reported

Planned enrollment30

PhasePhase 2

Primary outcome measureNumber of treatment-related serious adverse…

AUG 6, 2026 · PHASE 3 TRIAL

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and has not yet generated outcome data.

Preliminaryvicadrostat NCT06424288 Heart Failure

Reported

Planned enrollment6000

PhasePhase 3

Primary outcome measureTime to first event of CV death, hospitalis…

AUG 6, 2026 · PHASE 3 TRIAL

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcome data are not yet available, making it an ongoing investigation rather than evidence of efficacy.

Preliminaryvicadrostat Heart Failure NCT06935370

Reported

Planned enrollment4200

Study phasePhase 3

Primary outcome measureTime to first event of Cardiovascular death…